Publications

  1. Ma T, Schreiber CA, Knutson GJ, Khattouti AE, Sakiyama MJ, Hassan M, Charlesworth MC, Madden BJ, Zhou X, Vuk-Pavlovic S, Gomez CR. Effects of oxygen on the antigenic landscape of prostate cancer cells. BMC Res Notes 2015 Nov 18; 8:687
    View PubMed
  2. Vuk-Pavlovic S. Stemness as emergence. European Cells and Materials. 2013; 26(Suppl 3):1.
    View PubMed
  3. Gomez CR, Kosari F, Munz JM, Schreiber CA, Knutson GJ, Ida CM, El Khattouti A, Karnes RJ, Cheville JC, Vasmatzis G, Vuk-Pavlovic S. Prognostic value of discs large homolog 7 transcript levels in prostate cancer. PLoS One 2013; 8 (12):e82833 Epub 2013 Dec 09
    View PubMed
  4. Agur Z, Vuk-Pavlovic S. Personalizing immunotherapy balancing predictability and precision. Oncoimmunology. 2012 Oct; 1(7):1169-71.
    View PubMed
  5. Gomez CR, Knutson GJ, Clifton KB, Schreiber CA, Vuk-Pavlovic S. Age-dependent response of murine female bone marrow cells to hyperbaric oxygen. Biogerontology. 2012 Jun; 13(3):287-97. Epub 2012 Jan 24.
    View PubMed
  6. Vuk-Pavlovic S. Towards systems based immunotherapy of cancer. Period Biol. 2012 Jun; 114(2):187-99.
  7. Kogan Y, Halevi-Tobias K, Elishmereni M, Vuk-Pavlovic S, Agur Z. Reconsidering the paradigm of cancer immunotherapy by computationally aided real-time personalization. Cancer Res. 2012 May 1; 72(9):2218-27. Epub 2012 Mar 15.
    View PubMed
  8. Vuk-Pavlovic S. Biomathematical modeling and cancer immunotherapy: report of the workshop held at Bol, Island of Brac, Croatia, 20-21 June 2011. Cytotherapy. 2012 Feb; 14(2):144-6. Epub 2011 Oct 24.
    View PubMed
  9. Kronik N, Kogan Y, Elishmereni M, Halevi-Tobias K, Vuk-Pavlovic S, Agur Z. Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models. PLoS ONE. 2010 Dec 8; 5(11).
  10. Vuk-Pavlovic S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, Dietz AB. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate 2010 Mar 01; 70 (4):443-55
    View PubMed
  11. Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR, Melanoma Study. Metastatic malignant melanoma. G Ital Dermatol Venereol. 2009 Feb; 144(1):1-26.
    View PubMed
  12. Fisher PJ, Bulur PA, Vuk-Pavlovic S, Prendergast FG, Dietz AB. Dendritic cell microvilli: a novel membrane structure associated with the multifocal synapse and T-cell clustering. Blood. 2008 Dec 15; 112(13):5037-45. Epub 2008 Sep 19.
    View PubMed
  13. Ezzat MK, Hann CR, Vuk-Pavlovic S, Pulido JS. Immune cells in the human choroid. Br J Ophthalmol. 2008 Jul; 92(7):976-80.
    View PubMed
  14. Vuk-Pavlovic S. Rebuilding immunity in cancer patients. Blood Cells Mol Dis 2008 Jan-Feb; 40 (1):94-100 Epub 2007 Sept 10
    View PubMed
  15. Lopez de Padilla CM, Vallejo AN, McNallan KT, Vehe R, Smith SA, Dietz AB, Vuk-Pavlovic S, Reed AM. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum. 2007 May; 56(5):1658-68.
    View PubMed
  16. Dietz AB, Bulur PA, Emery RL, Winters JL, Epps DE, Zubair AC, Vuk-Pavlovic S. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion. 2006 Dec; 46(12):2083-9.
    View PubMed
  17. Markovic SN, Dietz AB, Greiner CW, Maas ML, Butler GW, Padley DJ, Bulur PA, Allred JB, Creagan ET, Ingle JN, Gastineau DA, Vuk-Pavlovic S. Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma. J Transl Med 2006 Aug 15; 4:35
    View PubMed
  18. Pavelic K, Primorac D, Vuk-Pavlovic S. Integrating new countries into the European Research Area. Croatian reflections on joining the European Union. EMBO Rep. 2006 May; 7(5):458-62.
    View PubMed
  19. Litzow MR, Dietz AB, Bulur PA, Butler GW, Gastineau DA, Hoering A, Fink SR, Letendre L, Padley DJ, Paternoster SF, Tefferi A, Vuk-Pavlovic S. Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML. Cytotherapy. 2006; 8(3):290-8.
    View PubMed
  20. Dietz AB, Markovic S, Greiner C, Maas M, Butler G, Bulur P, Suman V, Allred J, Vuk-Pavlovic S. Immunotherapy of malignant melanoma using a dendritic cell-amplified tumor RNA vaccine: A phase I study. J Clin Oncol 2005 Jun; 23 (16_suppl):2597
    View PubMed
  21. Bajzer Z, Vuk-Pavlovic S. Modeling positive regulatory feedbacks in cell-cell interactions. Biosystems. 2005 Apr; 80(1):1-10.
    View PubMed
  22. Aversa F, Berneman ZN, Locatelli F, Martelli MF, Reisner Y, Tabilio A, Velardi A, Vuk-Pavlovic S. Fourth international workshop on haploidentical transplants, Naples, Italy, July 8-10, 2004. Blood Cells Mol Dis. 2004 Nov-Dec; 33(3):159-75.
    View PubMed
  23. Dietz AB, Souan L, Knutson GJ, Bulur PA, Litzow MR, Vuk-Pavlovic S. Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood 2004 Aug 15; 104 (4):1094-9 Epub 2004 Apr 20
    View PubMed
  24. Burch PA, Croghan GA, Gastineau DA, Jones LA, Kaur JS, Kylstra JW, Richardson RL, Valone FH, Vuk-Pavlovic S. Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial. Prostate. 2004 Aug 1; 60(3):197-204.
    View PubMed
  25. Dietz AB, Padley DJ, Butler GW, Maas ML, Greiner CW, Gastineau DA, Vuk-Pavlovic S. Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma. Cytotherapy. 2004; 6(6):563-70.
    View PubMed
  26. Vuk-Pavlovic S. From hemoglobin structure to cancer immunotherapy: A very personal account. Period Biol. 2003 Sep; 105(3):201-5.
    View PubMed
  27. Antica M, Kusic B, Hranilovic D, Dietz AB, Vuk-Pavlovic S. Cloning the cDNA for murine U2 snRNP-A ' gene and its differential expression in lymphocyte development. Immunol Lett. 2002 Jul 3; 82(3):217-23.
    View PubMed
  28. Fisher PJ, Springett MJ, Dietz AB, Bulur PA, Vuk-Pavlovic S. Immunomagnetic separation reagents as markers in electron microscopy. J Immunol Methods. 2002 Apr 1; 262(1-2):95-101.
    View PubMed
  29. Dietz AB, Litzow MR, Gastineau DA, Vuk-Pavlovic S. Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: example of chronic myelogenous leukemia. Croat Med J. 2001 Aug; 42(4):428-35.
    View PubMed
  30. Vuk-Pavlovic S. Can there be a meaningful participation of Croat expatriates in Croatian science? Croat Med J. 2001 Aug; 42(4):356-8.
    View PubMed
  31. Matasic R, Dietz AB, Vuk-Pavlovic S. Maturation of human dendritic cells as sulfasalazine target. Croat Med J. 2001 Aug; 42(4):440-5.
    View PubMed
  32. Padley DJ, Dietz AB, Gastineau DA, Vuk-Pavlovic S. Mature myeloid dendritic cells for clinical use prepared from CD14+ cells isolated by immunomagnetic adsorption. J Hematother Stem Cell Res. 2001 Jun; 10(3):427-9.
    View PubMed
  33. Dietz AB, Bulur PA, Brown CA, Pankratz VS, Vuk-Pavlovic S. Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression. Gene Ther. 2001 Mar; 8(5):419-23.
    View PubMed
  34. Dietz AB, Litzow MR, Bulur PA, Vuk-Pavlovic S. Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells. Cytotherapy. 2001; 3(2):97-105.
    View PubMed
  35. Dietz AB, Bulur PA, Knutson GJ, Matasic R, Vuk-Pavlovic S. Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem Biophys Res Commun. 2000 Sep 7; 275(3):731-8.
    View PubMed
  36. Matasic R, Dietz AB, Vuk-Pavlovic S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology. 2000 Sep; 101(1):53-60.
    View PubMed
  37. Burch PA, Breen JK, Buckner JC, Gastineau DA, Kaur JA, Laus RL, Padley DJ, Peshwa MV, Pitot HC, Richardson RL, Smits BJ, Sopapan P, Strang G, Valone FH, Vuk-Pavlovic S. Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. Clin Cancer Res. 2000 Jun; 6(6):2175-82.
    View PubMed
  38. Dietz AB, Bulur PA, Erickson MR, Wettstein PJ, Litzow MR, Wyatt WA, Dewald GW, Tefferi A, Pankratz VS, Vuk-Pavlovic S. Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells. J Hematother Stem Cell Res. 2000 Feb; 9(1):95-101.
    View PubMed
  39. Bajzer Z, Vuk-Pavlovic S. New dimensions in gompertzian growth. J Theor Med. 2000; 2:307-15.
    View PubMed
  40. Matasic R, Dietz AB, Vuk-Pavlovic S. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol. 1999 Dec; 66(6):909-14.
    View PubMed
  41. Chen TB, Bajzer Z, Macura S, Vuk-Pavlovic S. Differences in metabolism of 5-fluorouracil and 5-fluorouridine and regulation by glucosamine in human colon cancer multicell tumor spheroids. NMR Biomed. 1999 May; 12(3):157-67.
    View PubMed
  42. Somlo G, Sniecinski I, ter Veer A, Longmate J, Knutson G, Vuk-Pavlovic S, Bhatia R, Chow W, Leong L, Morgan R, Margolin K, Raschko J, Shibata S, Tetef M, Yen Y, Forman S, Jones D, Ashby M, Fyfe G, Hellmann S, Doroshow JH. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy. Blood. 1999 May 1; 93(9):2798-806.
    View PubMed
  43. Dietz AB, Vuk-Pavlovic S. High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood. 1998 Jan 15; 91(2):392-8.
    View PubMed
  44. Juranic N, Vuk-Pavlovic S, Nikolic AT, Chen TB, Macura S. Nitrogen-15 NMR chemical shifts in oligopeptides coordinated to cobalt(III). J Inorg Biochem. 1996 May 1; 62(2):117-26.
    View PubMed
  45. Bajzer Z, Marusic M, Vukpavlovic S. Conceptual frameworks for mathematical modeling of tumor growth dynamics. Math Comput Model. 1996 Mar; 23(6):31-46.
  46. Vikic-Topic S, Raisch KP, Kvols LK, Vuk-Pavlovic S. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab. 1995 Oct; 80(10):2974-9.
    View PubMed
  47. Chen TB, Huzak M, Macura S, Vuk-Pavlovic S. Somatostatin analogue octreotide modulates metabolism and effects of 5-fluorouracil and 5-fluorouridine in human colon cancer spheroids. Cancer Lett 1994 Oct 28; 86 (1):41-51
    View PubMed
  48. Marusic M, Bajzer Z, Vuk-Pavlovic S, Freyer JP. Tumor growth in vivo and as multicellular spheroids compared by mathematical models. Bull Math Biol. 1994 Jul; 56(4):617-31.
    View PubMed
  49. Marusic M, Bajzer Z, Freyer JP, Vuk-Pavlovic S. Analysis of growth of multicellular tumour spheroids by mathematical models. Cell Prolif. 1994 Feb; 27(2):73-94.
    View PubMed
  50. Zelic A, Bajzer Z, Vuk-Pavlovic S. Endocyte (copyright) 1.2: an improved algorithm for quantitative analysis of receptor-mediated endocytosis. Int J Biomed Comput. 1993 Nov; 33:241-248.
    View PubMed
  51. Burke TW, Vuk-Pavlovic S. Insulin-like growth factor-I is a serum component stimulating growth of human neuroblastoma. In Vitro Cell Dev Biol Anim. 1993 May; 29A(5):391-4.
    View PubMed
  52. Marusic M, Vuk-Pavlovic S. Prediction power of mathematical models for tumor growth. J Biol Systems. 1993; 1:69-78.
  53. Zelic A, Bajzer Z, Vuk-Pavlovic S. EndoCyte, an interactive computer program for quantitative analysis of receptor-mediated endocytosis. Int J Biomed Comput. 1992 Jul; 31(1):59-70.
    View PubMed
  54. Bajzer Z, Vuk-Pavlovic S. Rate transition and regulatory coupling in endocytosis of interferon-alpha and tumor necrosis factor-alpha in human epithelial tumor cells. J Cell Biochem 1992 Feb; 48 (2):203-14
    View PubMed
  55. Marusic M, Bajzer Z, Freyer JP, Vuk-Pavlovic S. Modeling autostimulation of growth in multicellular tumor spheroids. Int J Biomed Comput. 1991 Nov; 29(2):149-58.
    View PubMed
  56. Marusic M, Bajzer Z, Vuk-Pavlovic S. Modeling hormone-dependent cell-cell interactions in tumor growth: a simulation study. Period Biol. 1991; 93:649-56.
  57. Vuk-Pavlovic S, Rohrbach MS. Induction of interleukin-1-beta release from human monocytes by bract tannin. Int Arch Allergy Appl Immunol. 1990 Apr; 91:394-397.
    View PubMed
  58. Bajzer Z, Vuk-Pavlovic S. Quantitative aspects of autocrine regulation in tumors. Crit Rev Oncog. 1990; 2(1):53-73.
    View PubMed
  59. Dunne S, Bajzer Z, Vuk-Pavlovic S. Kinetics of receptor mediated uptake and processing of interferon A2A and tumor necrosis factors-A by human tumor cells. Growth Factors. 1990; 2:167-177.
    View PubMed
  60. Vuk-Pavlovic S, Kovach JS. Recycling of tumor necrosis factor-alpha receptor in MCF-7 cells. FASEB J. 1989 Dec; 3(14):2633-40.
    View PubMed
  61. Bajzer Z, Myers AC, Vuk-Pavlovic S. Binding, internalization, and intracellular processing of proteins interacting with recycling receptors. A kinetic analysis. J Biol Chem. 1989 Aug 15; 264(23):13623-31.
    View PubMed
  62. Bajzer Z, Vuk-Pavlovic S. Quantitation of autocrine regulation of tumor growth: a general phenomenological model. Cancer Res. 1987 Oct 15; 47(20):5330-3.
    View PubMed
  63. Pavelic K, Bernacki RJ, Vuk-Pavlovic S. Insulin-modulated interleukin-2 production by murine splenocytes and a T-cell hybridoma. J Endocrinol. 1987 Jul; 114(1):89-94.
    View PubMed
  64. Myers AC, Kovach JS, Vuk-Pavlovic S. Binding, internalization, and intracellular processing of protein ligands. Derivation of rate constants by computer modeling. J Biol Chem. 1987 May 15; 262(14):6494-9.
    View PubMed
  65. Vuk-Pavlovic S, Opara EC, Levanat S, Vrbanec D, Pavelic K. Autocrine tumor growth regulation and tumor-associated hypoglycemia in murine melanoma B16 in vivo. Cancer Res. 1986 May; 46(5):2208-13.
    View PubMed
  66. Vuk-Pavlovic Z, Pavelic K, Vuk-Pavlovic S. Modulation of in vitro growth of murine myeloid leukemia by an autologous substance immunochemically cross-reactive with insulin and antiinsulin serum. Blood. 1986 Apr; 67(4):1031-5.
    View PubMed
  67. Baltic V, Levanat S, Petek M, Bratic-Mikes V, Pavelic K, Vuk-Pavlovic S. Elevated levels of substances immunologically cross-reactive with insulin in blood of patients with malignant and nonmalignant pulmonary tissue proliferation. Oncology. 1985; 42(3):174-8.
    View PubMed
  68. Bajzer Z, Pavelic K, Vuk-Pavlovic S. Growth self-incitement in murine melanoma B16: a phenomenological model. Science. 1984 Aug 31; 225(4665):930-2.
    View PubMed
  69. Pavelic L, Pavelic K, Vuk-Pavlovic S. Human mammary and bronchial carcinomas. In vivo and in vitro secretion of substances immunologically cross-reactive with insulin. Cancer. 1984 Jun 1; 53(11):2467-71.
    View PubMed
  70. Pavelic K, Vuk-Pavlovic S. C-peptide does not parallel increases of serum levels of substances immunologically cross-reactive with insulin in non-Hodgkin's lymphoma patients. Blood. 1983 May; 61(5):925-8.
    View PubMed
  71. Pavelic K, Sirotkovic M, Kopitar M, Pavelic J, Vuk-Pavlovic S. Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):123-6.
    View PubMed
  72. Pavelic K, Odavic M, Pekic B, Hrsak I, Vuk-Pavlovic S. Correlation of substance(s) immunologically cross-reactive with insulin, glucose and growth hormone in Hodgkin lymphoma patients. Cancer Lett. 1982 Oct; 17(1):81-6.
    View PubMed
  73. Vuk-Pavlovic S, Bozikov V, Pavelic K. Somatostatin-reduced proliferation of murine aplastic carcinoma conditioned to diabetes. Int J Cancer. 1982 Jun 15; 29(6):683-6.
    View PubMed
  74. Pavelic K, Bolanca M, Vecek N, Pavelic J, Marotti T, Vuk-Pavlovic S. Carcinomas of the cervix and corpus uteri in humans: stage-dependent blood levels of substance(s) immunologically cross-reactive with insulin. J Natl Cancer Inst. 1982 Jun; 68(6):891-4.
    View PubMed
  75. Vuk-Pavlovic S, Pavelic K. Towards in vitro verification of a hormone mediated feed-back mechanism of tumor growth. Period Biol. 1982; 84:336-7.
  76. Pavelic K, Ferle-Vidovic A, Osmak M, Vuk-Pavlovic S. Synthesis of immunoreactive insulin in vitro by aplastic mammary carcinoma preconditioned in diabetic mice. J Natl Cancer Inst. 1981 Sep; 67(3):687-8.
    View PubMed
  77. Pavelic K, Vuk-Pavlovic S. Retarded growth of murine tumors in vivo by insulin- and glucagon-stimulated immunity and phagocytosis. J Natl Cancer Inst. 1981 May; 66(5):889-92.
    View PubMed
  78. Blatt Y, Benko B, Pecht I, Vuk-Pavlovic S. Proton magnetic resonance relaxation in Pseudomonas aeruginosa cytochrome oxidase solutions. J Biol Chem. 1981 Mar 10; 256(5):2197-301.
    View PubMed
  79. Goldberg M, Vuk-Pavlovic S, Pecht I. Proton and oxygen-17 magnetic resonance relaxation in Rhus laccase solutions: proton exchange with type 2 copper(II) ligands. Biochemistry. 1980 Nov 11; 19(23):5181-9.
    View PubMed
  80. Benko B, Buljan V, Vuk-Pavlovic S. Concentration dependent proton magnetic cross-relaxation in aqueous polyoxyethylene solutions. J Phys Chem. 1980; 84:913-6.
  81. Vuk-Pavlovic S, Gafni A. 6-Aminohexanoic acid-plasminogen interactions studied by fluorescence. Biochem Biophys Res Commun. 1979 Dec 14; 91(3):971-5.
    View PubMed
  82. Vuk-Pavlovic S, Isenman DE, Elgavish GA, Gafni A, Licht A, Pecht I. Hapten-induced structural changes in rabbit immunoglobulin G with specifically mercuriated inter-heavy-chain disulfide. Biochemistry. 1979 Apr 3; 18(7):1125-9.
    View PubMed
  83. Vuk-Pavlovic S. Haem-induced structural analogies in proteins. Period Biol. 1979; 81:33-4.
  84. Pavelic K, Pavelic J, Benkovic B, Vuk-Pavlovic S. Correlation between hyperglycemia and reduced immune reactivity in mice. Int Res Commun System Med Sci. 1979; 8:24.
  85. Vuk-Pavlovic S, Blatt Y, Glaudemans CP, Lancet D, Pecht I. Hapten-linked conformational equilibria in immunolglobulins XRPC-24 and J-539 observed by chemical relaxation. Biophys J. 1978 Oct; 24(1):161-74.
    View PubMed
  86. Vuk-Pavlovic S, Williams-Smith DL. Fluoride and formate interaction with liver and erythrocyte catalases as revealed by solvent-proton magnetic relaxation. Biochemistry. 1977 Dec 13; 16(25):5465-70.
    View PubMed
  87. Vuk-Pavlovic S, Siderer Y. Probing axial ligands in ferric haemoproteins: an ESR study of myoglobin and horseradish peroxidase in H217O. Biochem Biophys Res Commun. 1977 Dec 7; 79(3):885-9.
    View PubMed
  88. Benko B, Vuk-Pavlovic S, Maricic S. Structural studies by proton magnetic relaxation of stereochemical probes. II. Allosteric effects in human methaemoglobin. Biochim Biophys Acta. 1977 Apr 25; 491(2):457-68.
    View PubMed
  89. Vuk-Pavlovic S, Bracika V, Benko B, Maricic S. A proton magnetic relaxation study of ferric myoglobin and haemoglobin in water/ethanediol solutions. Biochim Biophys Acta. 1977 Apr 25; 491(2):447-56.
    View PubMed
  90. Maricic S, Vuk-Pavlovic S, Benko B, Porok J, Rein H, Jaenig GR, Ruckpaul K. Solvent proton magnetic relaxation in solution of rabbit liver cytochrome P-450 - On the correlation time for the electron proton dipole-dipole interaction. Croat Chem Acta. 1977; 49:323-31.
  91. Rein H, Maricic A, Janig GR, Vuk-Pavlovic S, Benko B, Ristau O, Ruckpaul K. Haem accessibility in cytochrome P-450 from rabbit liver. A proton magnetic relaxation study by stereochemical probes. Biochim Biophys Acta. 1976 Sep 28; 446(1):325-30.
    View PubMed
  92. Vuk-Pavlovic S. The molecular mechanism of temperature enhancement of proton magnetic relaxation rates in methaemoprotein solutions. III. The effect of sixth ligand in high-spin derivatives. Biophys Chem. 1976 Sep; 5(3):395-8.
    View PubMed
  93. Benko B, Vuk-Pavlovic S. Nitrosyl haemoglobin: the NO-spin as a relaxation probe in the solvent-proton magnetic resonance experiment demonstrating the phosphate-induced widening of the haem-pocket. Biochem Biophys Res Commun. 1976 Aug 23; 71(4):1303-7.
    View PubMed
  94. Vuk-pavlovic S, Benko B, Maricic S, Lahajnar G, Kuranova IP, Vainshtein BK. The haem-accessibility in leghaemoglobin of Lupinus luteus as observed by proton magnetic relaxation. International Journal of Peptide & Protein Research. 1976; 8(5):427-34.
    View PubMed
  95. Benko B, Vuk-Pavlovic S, Pommerening K. Matrix bound haemoglobin as seen by proton magnetic relaxation. Stud Biophys. 1976; 55:157-61.
  96. Ruckpaul K, Maricic S, Jaenig GR, Benko B, Vuk-Pavlovic S, Rein H. Hepatic cytochrome P-450. A proton magnetic relaxation study of microsomal, solubilized and partially reconstituted enzyme system. Croat Chem Acta. 1976; 48:69-86.
  97. Vuk-Pavlovic S, Benko B, Efremov GD, Markovska B. A proton magentic relaxation study of isolated sheep methaemoglobins A, B and C and of their interaction with inositol hexaphosphate. Int J Biochem. 1976; 7:235-7.
  98. Vuk-Pavlovic S, Benko B, Maricic S, Markovska B, Efremov GD. The haem-accessibility to solvent and allosteric effects in different protomers of human haemoglobins as observed by proton magnetic relaxation. Int J Biochem. 1976; 7:367-70.
  99. Vuk Pavlovic S. Evolution of the haem-haem interaction in vertebrate haemoglobins - a hypothesis. J Mol Evol. 1975 Nov 4; 6(3):209-14.
    View PubMed
  100. Markovska B, Efremov GD, Vuk-pavlovic S, Benko B, Maricic S. Structural nonequivalence of the alpha- and beta- heme-pockets in human methemoglobin. A proton magnetic relaxation study in solution. Arch Biochem Biophys. 1975 Nov; 171(1):337-42.
    View PubMed
  101. Vuk-Pavlovic S, Benko B. The haem-enviroment in horseradish peroxidase as seen by proton magnetic relaxation. Biochem Biophys Res Commun. 1975 Oct 27; 66(4):1154-9.
    View PubMed
  102. Benko B, Vuk-Pavlovic S, Dezelic GJ, Maricic S. A proton magnetic relaxation study of methaemoproteins bound to monodisperse polystyrene latex particles. J Colloid Interface Sci. 1975; 52:444-51.
  103. Vuk-Pavlovic S, Benko B, Maricic S. The molecular mechanism of the temperature enhancement of proton magnetic relaxation rates in methaemoprotein solutions. Biophys Chem. 1974 Dec; 2(4):359-68.
    View PubMed
  104. Pifat G, Benko B, Maricic S, Vuk-Pavlovic S. A proton magnetic relaxation study of the interaction between methaemoglobin and inositol hexaphosphate. Croat Chem Acta. 1974; 46:145-55.
  105. Brnjas-Kraljevic J, Maricic S, Vuk-Pavlovic S. Proton magnetic relaxation in ethanediol-water solutions of haemoglobin. Croat Chem Acta. 1973; 45:619-25.